SXRW 📈 iShares VII - iShares FTSE - Overview

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B53HP851 • UK Large-Cap Equity

SXRW: Equity, Stocks, ETF, Index, Fund

‣ Company URL: http://www.blackrock.com ‣ Domicile: Ireland ‣ Index Name: Morningstar UK All Cap TME NR GBP

Additional Sources for SXRW ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

SXRW ETF Overview

Market Cap in USD 2,271m
Category UK Large-Cap Equity
TER 0.07%
IPO / Inception 2010-01-26

SXRW ETF Ratings

Growth 5y 58.0%
Fundamental -
Dividend -
Rel. Strength Industry -23.9
Analysts -
Fair Price Momentum 184.29 EUR
Fair Price DCF -

SXRW Dividends

No Dividends Paid

SXRW Growth Ratios

Growth Correlation 3m 23%
Growth Correlation 12m 91.9%
Growth Correlation 5y 94.4%
CAGR 5y 5.39%
CAGR/Mean DD 5y 0.79
Sharpe Ratio 12m 0.79
Alpha -5.52
Beta 0.64
Volatility 14.27%
Current Volume 1.7k
Average Volume 20d 3.3k
What is the price of SXRW stocks?
As of January 03, 2025, the stock is trading at EUR 190.04 with a total of 1,727 shares traded.
Over the past week, the price has changed by -0.37%, over one month by -2.19%, over three months by -0.79% and over the past year by +13.67%.
Is iShares VII - iShares FTSE a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares VII - iShares FTSE (XETRA:SXRW) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.02 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SXRW as of January 2025 is 184.29. This means that SXRW is currently overvalued and has a potential downside of -3.03%.
Is SXRW a buy, sell or hold?
iShares VII - iShares FTSE has no consensus analysts rating.
What are the forecast for SXRW stock price target?
According to ValueRays Forecast Model, SXRW iShares VII - iShares FTSE will be worth about 202.6 in January 2026. The stock is currently trading at 190.04. This means that the stock has a potential upside of +6.62%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 202.6 6.6%